sorbitol has been researched along with debrisoquin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chalon, SA; Desager, JP; Desante, KA; Frye, RF; Golnez, JL; Horsmans, Y; Long, AJ; Sauer, JM; Smith, BP; Thomasson, HR; Witcher, J | 1 |
2 other study(ies) available for sorbitol and debrisoquin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
Topics: Administration, Oral; Adult; Antidepressive Agents; Area Under Curve; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Cytochrome P-450 CYP2D6; Debrisoquin; Female; Humans; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Propylamines; Severity of Illness Index; Sorbitol | 2003 |